Unibest
← Back to patent-cliff list

Brilaroxazine

Tier C — Watch / trade

Brilaroxazine

Reviva Pharmaceuticals Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:5-HT1A, DRD4, DRD3, DRD2, 5-HT7, 5-HT6, 5-HT2A

Indications (approved):Schizophrenia, Major depressive disorder, Pulmonary arterial hypertension, Idiopathic pulmonary fibrosis, Mania, Attention deficit hyperactivity disorder, Psoriasis

Regional status

US
Phase III
2022-01-24
EU
No progress
2011-12-01
China
-
Japan
-

Synthetic routes & intermediates1 routes

Originator routes × 0Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OptimisedRoute 1Steps 6 · Total yield 0.28 g
RP-5063—RP-5063-0011568-70-3RP-5063-002109364-95-6RP-5063-003103942-21-8RP-5063-004110-52-1RP-5063-0051197155-12-6RP-5063-006119532-26-2RP-5063-0071239729-01-1RP-5063-0081239729-06-6API · Brilaroxazine
CodeCAS No.Intermediate
RP-5063--
RP-5063-0011568-70-3Available4-methoxy-2-nitrophenol
RP-5063-002109364-95-6Availableethyl 2-(4-methoxy-2-nitrophenoxy)acetate
RP-5063-003103942-21-8Availableethyl 2-(4-hydroxy-2-nitrophenoxy)acetate
RP-5063-004110-52-1Available1,4-dibromobutane
RP-5063-0051197155-12-6Availableethyl 2-(4-(4-bromobutoxy)-2-nitrophenoxy)acetate
RP-5063-006119532-26-2Available1-(2,3-dichlorophenyl)piperazine hydrochloride
RP-5063-0071239729-01-1Availableethyl 2-(4-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-nitrophenoxy)acetate
RP-5063-0081239729-06-6Available6-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one

Frequently asked questions

What are the approved indications of Brilaroxazine?

Approved indications include: Schizophrenia, Major depressive disorder, Pulmonary arterial hypertension, Idiopathic pulmonary fibrosis, Mania, Attention deficit hyperactivity disorder, Psoriasis.

When does the Brilaroxazine patent expire?

No public expiry year is available for Brilaroxazine yet; this page updates once verified.

How many synthesis routes are recorded for Brilaroxazine?

1 synthesis routes are recorded; the shortest is 6 steps with 0.28 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Brilaroxazine intermediates?

8 intermediate CAS of Brilaroxazine are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Brilaroxazine intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-05